{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T02:12:23Z","timestamp":1782526343948,"version":"3.54.5"},"reference-count":66,"publisher":"Media Sphere Publishing House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2023,3,22]]},"abstract":"<jats:p>Objective. To evaluate the efficacy and safety of combination therapy for post-COVID asthenic syndrome with multicomponent bioregulatory drugs Traumeel S, Ubichinon compositum and Coenzyme compositum. Material and methods. The study included 104 patients (averaged age 39.5 [30.8; 48] years) after COVID-19, clinically recovered from an acute infectious process, with asthenic syndrome lasting from 2 weeks to 6 months; the severity of asthenic syndrome on the asthenia VAS scale was at least 30 points. Before the start of the study, in addition to a physical examination, the patient\u2019s condition was assessed using the following questionnaires and scales: VAS for asthenia, subjective scale for assessing asthenia (MFI-20), L.D. Malkova, a questionnaire for the quality of life (EQ-5D), a questionnaire for identifying signs of autonomic disorders (Vayne A.M.). The patient\u2019s condition was monitored during follow-up visits 2 weeks, 1 month after the start of treatment and 1 month after the end of treatment. Patients of the main group received combination therapy, which included Traumeel S 1 tablet x 3 times a day, Ubichinone compositum and Coenzyme compositum 2.2 ml intramuscularly, alternating every other day, for 1 month (15 injections of each drug per course of treatment). Patients of the comparison group received eleutherococcus extract 100 mg during 30 days, 2 tablets x 2 times a day before mealsand vitamins B. The effectiveness of therapy was assessed by analysis of the asthenia severity (VAS scale), quality of life (EQ-5D questionnaire), patient satisfaction with treatment on a 5-point scale, which was carried out 1 month after the end of the course of treatment. Results. As a result of the treatment was positive. The general asthenia severity, low activity and motivation significantly decreased in patients of both groups without significant differences. At the same time, in patients of the comparison group, there was no correlation between the quality of life and physical and mental asthenia, while in the main group there was an inverse correlation with the asthenia severity, which indicates an increase in the quality of life with a decrease in the severity of asthenia. One of the significant differences was the regression of headache and musculoskeletal pain in patients of the main group. Conclusion. The advantage of combined therapy of post-COVID asthenic syndrome with bioregulation therapy Traumeel  S, Ubichinone compositum and Coenzyme compositum was shown in comparison with one of the common treatment regimens, including eleutherococcus extract and combined preparations of B vitamins.<\/jats:p>","DOI":"10.17116\/jnevro202312303161","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T11:01:44Z","timestamp":1679482904000},"page":"61","source":"Crossref","is-referenced-by-count":10,"title":["Asthenic post-COVID syndrome"],"prefix":"10.17116","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6883-7649","authenticated-orcid":false,"given":"D.Kh.","family":"Khaibullina","sequence":"first","affiliation":[{"name":"Kazan State Medical Academy \u2014 branch of the Russian Medical Academy of Continuing Professional Education","place":["Kazan, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1430-9741","authenticated-orcid":false,"given":"Y.N.","family":"Maksimov","sequence":"additional","affiliation":[{"name":"Kazan State Medical Academy \u2014 branch of the Russian Medical Academy of Continuing Professional Education","place":["Kazan, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202312303161-1","unstructured":"Shabrov AV, Solov\u2019eva SL Astenicheskie rasstrojstva v terapevticheskoj praktike. Ruk-vo po diagnostike i lecheniju. SPb., 2010. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-2","unstructured":"Myakotnykh VS, Ostapchuk ES, Postovalova VL. Osnovnyye zabolevaniya i sindromy, vyyavlennyye u patsiyentov pozhilogo i starcheskogo vozrasta, gospitalizirovannykh v statsionary raznogo profilya. Uspekhi Gerontologii. 2018;31(2):250-259. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-3","unstructured":"Akarachkova ES. K voprosu diagnostiki i lechenija psihovegetativnyh rasstrojstv v obshhesomaticheskoj praktike. Lechashhij Vrach. 2010;10:60-64. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-4","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED-D-15-00085"},{"key":"key-10.17116\/jnevro202312303161-5","unstructured":"Kotova OV, Akarachkova ES. Asthenic syndrome in neurological and family doctor practice. RMJ. 2016;13:824-829. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-6","unstructured":"International classification of diseases 11 revision of ICD10. Accessed January 23, 2023. (In Russ.). https:\/\/classinform.ru\/mkb-10.html"},{"key":"key-10.17116\/jnevro202312303161-7","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-017-0614-4"},{"key":"key-10.17116\/jnevro202312303161-8","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.87.9.1449"},{"key":"key-10.17116\/jnevro202312303161-9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-1879"},{"key":"key-10.17116\/jnevro202312303161-10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-13"},{"key":"key-10.17116\/jnevro202312303161-11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38933.585764.AE"},{"key":"key-10.17116\/jnevro202312303161-12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-12-199412150-00009"},{"key":"key-10.17116\/jnevro202312303161-13","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10121012"},{"key":"key-10.17116\/jnevro202312303161-14","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.690383"},{"key":"key-10.17116\/jnevro202312303161-15","unstructured":"COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE). 2020;18.  https:\/\/pubmed.ncbi.nlm.nih.gov\/33555768\/"},{"key":"key-10.17116\/jnevro202312303161-16","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare8040552"},{"key":"key-10.17116\/jnevro202312303161-17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117271"},{"key":"key-10.17116\/jnevro202312303161-18","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26368"},{"key":"key-10.17116\/jnevro202312303161-19","doi-asserted-by":"publisher","DOI":"10.33588\/rn.7211.2021230"},{"key":"key-10.17116\/jnevro202312303161-20","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102841"},{"key":"key-10.17116\/jnevro202312303161-21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95565-8"},{"key":"key-10.17116\/jnevro202312303161-22","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18084350"},{"key":"key-10.17116\/jnevro202312303161-23","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04882-8"},{"key":"key-10.17116\/jnevro202312303161-24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603"},{"key":"key-10.17116\/jnevro202312303161-25","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2021.1924397"},{"key":"key-10.17116\/jnevro202312303161-26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103512"},{"key":"key-10.17116\/jnevro202312303161-27","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15459"},{"key":"key-10.17116\/jnevro202312303161-28","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.0c00122"},{"key":"key-10.17116\/jnevro202312303161-29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244"},{"key":"key-10.17116\/jnevro202312303161-30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.07.020"},{"key":"key-10.17116\/jnevro202312303161-31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.06.001"},{"key":"key-10.17116\/jnevro202312303161-32","doi-asserted-by":"publisher","DOI":"10.32364\/2587-6821-2021-5-10-636-641"},{"key":"key-10.17116\/jnevro202312303161-33","doi-asserted-by":"crossref","unstructured":"Zakharov DV, Buriak YuV. The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment. Bekhterev Review of Psychiatry and Medical Psychology. 2021;55(4):97-105. (In Russ.)","DOI":"10.31363\/2313-7053-2021-57-4-97-105"},{"key":"key-10.17116\/jnevro202312303161-34","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2021-4-88-93"},{"key":"key-10.17116\/jnevro202312303161-35","doi-asserted-by":"publisher","DOI":"10.46393\/2712-9675_2021_2_14_22"},{"key":"key-10.17116\/jnevro202312303161-36","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro202112108125"},{"key":"key-10.17116\/jnevro202312303161-37","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2021-4-220-229"},{"key":"key-10.17116\/jnevro202312303161-38","doi-asserted-by":"publisher","DOI":"10.17116\/profmed20212404176"},{"key":"key-10.17116\/jnevro202312303161-39","doi-asserted-by":"publisher","DOI":"10.30906\/0869-2092-2020-83-10-40-43"},{"key":"key-10.17116\/jnevro202312303161-40","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2021-3-93-98"},{"key":"key-10.17116\/jnevro202312303161-41","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro2021121081125"},{"key":"key-10.17116\/jnevro202312303161-42","unstructured":"Naumov KM, Andreeva GO, Bazhenov DA. Differentiated approach to the correction of autonomic disorders in long COVID-19. Russian Military Medical Academy Reports. 2021;40(S4):88-91. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-43","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2021-5-96-101"},{"key":"key-10.17116\/jnevro202312303161-44","doi-asserted-by":"publisher","DOI":"10.47360\/1995-4484-2021-255-262"},{"key":"key-10.17116\/jnevro202312303161-45","doi-asserted-by":"publisher","DOI":"10.31550\/1727-2378-2021-20-7-7-11"},{"key":"key-10.17116\/jnevro202312303161-46","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-022-00654-z"},{"key":"key-10.17116\/jnevro202312303161-47","doi-asserted-by":"publisher","DOI":"10.1089\/acu.2021.0086"},{"key":"key-10.17116\/jnevro202312303161-48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2022.102823"},{"key":"key-10.17116\/jnevro202312303161-49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2007.04.004"},{"key":"key-10.17116\/jnevro202312303161-50","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12219"},{"key":"key-10.17116\/jnevro202312303161-51","unstructured":"Dydykina IS, Kovalenko PS, Naumov AV, Zotkin EG. Possibilities of complex bioregulatory drugs in the treatment of diseases of the musculoskeletal system. Effective Pharmacotherapy. 2019;15(8):24-31. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00225"},{"key":"key-10.17116\/jnevro202312303161-53","doi-asserted-by":"publisher","DOI":"10.33978\/2307-3586-2020-16-6-16-20"},{"key":"key-10.17116\/jnevro202312303161-54","unstructured":"van Haselen R. An Integrative Review of the Evidence on the Antihomotoxic Medication Traumeel. RMJ. 2017;3:185-197. (In Russ.). https:\/\/www.rusmedreview.com\/upload\/iblock\/cb5\/185-197.pdf"},{"key":"key-10.17116\/jnevro202312303161-55","doi-asserted-by":"publisher","DOI":"10.21518\/2079-701X-2020-8-95-101"},{"key":"key-10.17116\/jnevro202312303161-56","doi-asserted-by":"crossref","unstructured":"Pilipovich AA. The efficacy of Traumeel S in terms of evidence-based medicine. Consilium Medicum. 2017;19(2):157-162. (In Russ.)","DOI":"10.26442\/2075-1753_19.2.157-162"},{"key":"key-10.17116\/jnevro202312303161-57","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-006-9190-z"},{"key":"key-10.17116\/jnevro202312303161-58","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-039358"},{"key":"key-10.17116\/jnevro202312303161-59","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009835"},{"key":"key-10.17116\/jnevro202312303161-60","doi-asserted-by":"publisher","DOI":"10.1016\/j.biosystems.2016.03.003"},{"key":"key-10.17116\/jnevro202312303161-61","doi-asserted-by":"publisher","DOI":"10.30895\/1991-2919-2019-9-3-146-152"},{"key":"key-10.17116\/jnevro202312303161-62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08899-7"},{"key":"key-10.17116\/jnevro202312303161-63","unstructured":"Gurtovenko IYu. The use of drugs Coenzyme compositum and Ubichinon Compositum at the recovery stage of treatment of patients with coronary heart disease (angina pectoris II fc). Bulletin of New Medical Technologies. 2006;XIII(3):80-83. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-64","unstructured":"Bianchi I. Coenzyme compositum and Ubiquinone compositum and their role in supporting mitochondrial functions. Biological Medicine 2016;1:16-32. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-65","unstructured":"Vein AM. Zabolevaniya vegetativnoi nervnoi sistemy. Rukovodstvo dlya vrachei. M.: Meditsina; 1991. (In Russ.)"},{"key":"key-10.17116\/jnevro202312303161-66","unstructured":"Glants S. Mediko-biologicheskaya statistika. M.: Praktika; 1998. (In Russ.)"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:46:28Z","timestamp":1745487988000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2023\/3\/1199772982023031061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,22]]}},"alternative-id":["10.17116\/jnevro202312303161"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202312303161","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}